The global diabetic shoes market is poised for substantial growth, with a projected valuation of USD 8.6 billion in 2023. Over the next decade, the market is expected to expand at a compound annual growth rate (CAGR) of 6.4%, reaching a value of USD 16.0 billion by 2033.
The increasing prevalence of diabetes worldwide, along with the rising awareness of foot care and prevention of complications such as diabetic neuropathy, is driving the demand for specialized diabetic footwear. These shoes are designed to provide enhanced comfort, reduce pressure points, and promote better foot health, making them a vital product for diabetic patients.
The team of analysts at Future Market Insights are focussing on research and market study to produce different Diabetic Shoes Market forecasts and predictions at both national and international levels.
They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Diabetic Shoes Market.
The global demand for diabetic shoes is predicted to witness a healthy CAGR of 6.4% between 2023 and 2033, in comparison to the 4.1% CAGR registered from 2017 to 2022. Growth in the diabetic shoes market is attributed to the increase in the prevalence of diabetes, growing awareness about the availability of medical footwear products across developing regions, increasing need for better foot care, new product launches, and favorable government support.
Diabetic shoes are unique footwear products designed to preserve diabetic feet, as well as to reduce skin breakdown due to neuropathy, impaired mobility, and deformities. These diabetic shoes have flexible uppers and an extra-thickness design for a pressure-free fit. They provide better motion control, prevent skin breakdown, promote circulation, reduce calluses formation, and thus eliminate the risk of foot problems in high-pressure areas of the foot.
The rapid surge in cases of diabetes and diabetic ulcers is a significant factor boosting growth of the market. According to the International Diabetes Federation (IDF), diabetic foot and lower limb complications have become serious health problems, affecting 40 to 60 million people with diabetes globally. These health conditions (chronic ulcers and amputations) significantly reduce the quality of life and increase the risk of early death. To counter this and minimize the risk of infections, people use preventive healthcare products like diabetic shoes. This is likely to continue to expand the global diabetic shoes market size during the forecast period.
Competitive Landscape
In the diabetic footwear market, leading competitors are focusing on providing specialized solutions as a key strategy to capture a significant share of the market. Major players have successfully leveraged strategies such as product launches and acquisitions to strengthen their positions within the diabetic footwear sector.
Recent Developments:
- In December 2021, Casa Everz GmbH, the owner of the German footwear brand Von Wellx, introduced a new line of diabetic footwear. These innovative sneakers are designed using internationally patented reaction zones technology and were developed by renowned physician Dr. Walter Mauch.
- Anodyne, LLC, a prominent provider of clinical footwear specifically designed for diabetic patients, announced in May 2022 that HealthEdge Investment Partners, LLC, a private equity firm with a focus on healthcare, has made an investment in the company.
- In May 2022, Enovis, a global leader in medical technology, acquired 360 Med Care Pty Ltd, an Australian orthopedic firm, with the aim of enhancing patient outcomes throughout the orthopedic care process.
Key Segments Covered in the Diabetic Shoes Market Report
By Product Type:
- Dress Shoes
- Running Shoes
- Strolling Shoes
- Others
By Patient Type:
- Outpatient
- Inpatient
By End User:
- Men
- Women
By Width:
- Narrow
- Medium
- Wide
- Others
By Sales Channel:
- Direct Sales
- Footwear Specialty Stores
- Medical & Healthcare Centers
- Online Retailers
- Mono-brand Stores
- Other Sales Channel
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific excluding Japan (APEJ)
- Japan
- The Middle East & Africa (MEA)
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
